Menopause and Risk Factors for Coronary Heart Disease

New England Journal of Medicine

Volumn 321, Issue 10, 1989, Pages 641-646

  Matthews, Karen A ^a,b   Meilahn, Elaine ^a   Kuller, Lewis H ^a   Kelsey, Sheryl F ^a   Caggiula, Arlene W ^a   Wing, Rena R ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTROGEN; GESTAGEN;

AGE; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL;

EID: 0024422169     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198909073211004     Document Type: Article

References (29)

1. Oliver MF, Boyd GS. Effect of bilateral ovariectomy on coronary-artery disease and serum-lipid levels. Lancet 1959; 2: 690–4.
2. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease: the Framingham study. Ann Intern Med 1978; 89: 157–61.
3. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976; 85: 447–52.
4. Willett W, Stampfer MJ, Bain C, et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol 1983; 117: 651–8.
5. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105–10.
6. Campos H, McNamara JR, Wilson PW, Ordovas JM, Schaefer EJ. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metab 1988; 67: 30–5.
7. Hallberg L, Svanborg A. Cholesterol, phospholipids, and triglycerides in plasma in 50-year old women: influence of menopause, body-weight, skinfold thickness, weight-gain, and diet in a random population sample. Acta Med Scand 1967; 181: 185–94.
8. Krauss RM, Lindgren FT, Wingerd J, Bradley DD, Ramcharan S. Effects of estrogens and progestins on high density lipoproteins. Lipids 1979; 14: 113–8.
9. Wallace RB, Hoover J, Barrett-Connor E, et al. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use: report from the Medications Working Group of the Lipid Research Clinics program. Lancet 1979; 2: 112–5.
10. Bain C, Willett W, Hennekens CH, Rosner B, Belanger C, Speizer FE. Use of postmenopausal hormones and risk of myocardial infarction. Circulation 1981; 64: 42–6.
11. Lindquist O. Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: results from a prospective population study of women in Goteborg, Sweden. Prev Med 1982; 11: 162–72.
12. Bengtsson C, Lapidus L, Lindquist O. Association between menopause and risk factors for ischaemic heart disease. In: Oliver MF, Vedin A, Wilhelmsson C, eds. Myocardial infarction in women. Edinburgh: Churchill Livingstone, 1986:93–100.
13. Hjortland MC, McNamara PM, Kannel WB. Some atherogenic concomitants of menopause: the Framingham study. Am J Epidemiol 1976; 103: 304–11.
14. Garrow JS. Zero-muddler for unprejudiced sphygmomanometry. Lancet 1963; 2: 1205.
15. Dischinger P, DuChene AG. Quality control aspects of blood pressure measurements in the Multiple Risk Factor Intervention Trial. Controlled Clin Trials 1986; 7:Suppl:137S–157S.
16. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470–5.
17. Warnick GR, Albers JJ. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978; 19: 65–76.
18. Gidez LI, Miller GJ, Burstein M, et al. Analyses of plasma high density lipoprotein subclasses by a precipitation procedure: correlations with preparative and analytical centrifugation. In: Lippel K, ed. Report of the High Density Lipoprotein Methodology Workshop, San Francisco, California, March 12, 13, and 14, 1979. Bethesda, Md.: Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, 1979:328–42. (NIH publication no. 79–1661.)
19. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476–82.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
21. Mendoza SG, Zerpa A, Carrasco H, et al. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery 1983; 12: 1–23.
22. Stein EA, DiPersio L, Pesce AJ, et al. Enzyme-linked immunoabsorbant assay of apolipoprotein AII in plasma, with use of a monoclonal antibody. Clin Chem 1986; 32: 967–71.
23. Herbert V, Lauk K-S, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965; 25: 1375–84.
24. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978; 108: 161–75.
25. Adams CF. Nutritive value of American foods in common units. Agriculture handbook no. 456. Washington, D.C.: Agricultural Research Service, Department of Agriculture, 1975.
26. Nutrition Coordinating Center. Reference food table, version 10. Minneapolis: University of Minnesota, 1984.
27. McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med 1985; 103: 350–6.
28. Meilahn EN, Kuller LH, Stein EA, Caggiula A, Matthews KA. Characteristics associated with apoprotein and lipoprotein lipid levels in middle-aged women. Arteriosclerosis 1988; 8: 515–20.
29. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up study. Circulation 1987; 75: 1102–9.